Metagenomi, Inc.

Metagenomi, Inc.

Biotechnology • Healthcare • EmeryVille, CA, United States • MGX (NMS)

Metagenomi, Inc., a genetic medicines company, develops therapeutics for patients using metagenomics-derived genome editing toolbox in the United States. Its genome editing toolbox includes nuclease-based genome editing, base editors, RNA-mediated integration, including prime editing, and DNA-mediated integration, such CRISPR-associated transposases. The company has a collaboration and license agreement with Ionis Pharmaceuticals, Inc. to research, develop and commercialize investigational medicines using genome editing technologies; and a development, option, and license agreement with Affini-T Therapeutics, Inc. to develop and commercialize gene edited TCR-based therapeutic products exclusively in the field of treatment, prevention, or diagnosis of any human cancer. Metagenomi, Inc. was incorporated in 2016 and is headquartered in Emeryville, California.

510 871 4880 5959 Horton Street, EmeryVille, CA 94608, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Metagenomi (Nasdaq: MGX) cuts workforce 25%, appoints CEO; cash runway into 2027 - Stock Titan
Stock Titan • Nov 11
Metagenomi Chops 25% of Workforce, CEO To Advance Hemophilia A Program - BioSpace
BioSpace • Nov 12
Here's Why Metagenomi (MGX) is a Great Momentum Stock to Buy - Yahoo Finance
Yahoo Finance • Oct 20
Irish Jian, Metagenomi CEO, sells $2899 in MGX stock - Investing.com
Investing.com • Dec 24
Oracle stock jumps 7% as cloud provider joins investor group to run TikTok's U.S. business - CNBC
CNBC • Dec 19

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Metagenomi, Inc. had layoffs?
No layoff events have been recorded for Metagenomi, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Metagenomi, Inc. have?
Metagenomi, Inc. has approximately 124 employees.
What industry is Metagenomi, Inc. in?
Metagenomi, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Metagenomi, Inc. a publicly traded company?
Yes, Metagenomi, Inc. is publicly traded under the ticker symbol MGX on the NMS. The company has a market capitalization of approximately $0.06 billion.
Where is Metagenomi, Inc. headquartered?
Metagenomi, Inc. is headquartered in EmeryVille, CA, United States at 5959 Horton Street, EmeryVille, CA 94608, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.